CDC revises recommendations for postpartum use of combined hormonal contraceptives

Article

Based on new scientific evidence, the Centers for Disease Control and Prevention (CDC) has updated its US Medical Eligibility Criteria for Contraceptive Use, 2010, issuing revised recommendations for the use of combined hormonal contraceptives by postpartum women.

Based on new scientific evidence, the Centers for Disease Control and Prevention (CDC) has updated its US Medical Eligibility Criteria for Contraceptive Use, 2010, issuing revised recommendations for the use of combined hormonal contraceptives by postpartum women.

Because of the high risk for venous thromboembolism (VTE), women shouldn’t use combined hormonal contraceptives during the first 21 days after delivery, the CDC advises. Women with no risk factors for VTE usually can start the contraceptives between 21 and 42 days postpartum. Women with risk factors for VTE (previous VTE or recent cesarean delivery) generally shouldn’t use this type of contraception. Beyond 42 days after delivery, no restrictions based on postpartum status apply.

CDC recommendations for other contraceptives, including progestin-only contraceptives and intrauterine devices, remain unchanged. These contraceptives can be started immediately after delivery and are safe for postpartum women, including women who are breastfeeding.

The US Medical Eligibility Criteria for Contraceptive Use, 2010 are at http://www.cdc.gov/reproductivehealth/UnintendedPregnancy/USMEC.htm.

Recent Videos
Supreme Court upholds mifepristone access: Implications for women's health | Image Credit: linkedin.com
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
© 2024 MJH Life Sciences

All rights reserved.